Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3

NCT06322992 is registered in ClinicalTrials.gov with Daynamica, Inc. as lead sponsor.

NCT NCT06322992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06322992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3
Lead sponsor
Daynamica, Inc.
Phase
Observational
Overall status
Completed
Start date
May 14, 2024
Completion date
October 20, 2024
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer